Ernest H Law & Chris Cameron. (2023). Letter in Reply: Indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant. Becaris Publishing Limited.
Chicago Style (17th ed.) CitationErnest H Law and Chris Cameron. Letter in Reply: Indirect Comparison of Quality-of-life Scores Between Patients with Advanced Breast Cancer Receiving Palbociclib and Abemaciclib in Combination with Fulvestrant. Becaris Publishing Limited, 2023.
MLA (9th ed.) CitationErnest H Law and Chris Cameron. Letter in Reply: Indirect Comparison of Quality-of-life Scores Between Patients with Advanced Breast Cancer Receiving Palbociclib and Abemaciclib in Combination with Fulvestrant. Becaris Publishing Limited, 2023.